Eomesodermin+ CD4+ T cells are critical for curative immunotherapy outcomes

Journal:

Immunity

Published:

2025-10-02

DOI:

10.1016/j.immuni.2025.09.004

Affiliations:

5

Authors:

20

Go to article

Institutions	Authors	Share
Fred Hutchinson Cancer Center, United States of America (USA)	14.500000 14.500000	0.73
Clinical Research Division, FHCRC, United States of America (USA)	2.500000	0.13
QIMR Berghofer Medical Research Institute, Australia	1.500000	0.08
Envoi Pathology, Australia	1.000000	0.05
University of Washington (UW), United States of America (USA)	0.500000	0.03

Interested in Immunology?